Clinical Trial Update: Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial of ridaforolimus and vorinostat in advanced solid tumors or lymphoma completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• Ridaforolimus (ridaforolimus)
• Vorinostat (vorinostat)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED | Results posted: 2021-02-21